BioPlus Acquisition (BioPlus Acquisition) EV-to-EBIT

BioPlus Acquisition Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
EV-to-EBIT						-525.84	-351.47	-259.96	-273.25	-97.83

For the Shell Companies subindustry, BioPlus Acquisition's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

For the Diversified Financial Services industry and Financial Services sector, BioPlus Acquisition's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where BioPlus Acquisition's EV-to-EBIT falls into.

BioPlus Acquisition EV-to-EBIT Calculation

BioPlus Acquisition's EV-to-EBIT for today is calculated as:

BioPlus Acquisition's current Enterprise Value is $214.32 Mil.
BioPlus Acquisition's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.16 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioPlus Acquisition  (NAS:BIOS) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

BioPlus Acquisition's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2023 is calculated as:

BioPlus Acquisition's Enterprise Value for the quarter that ended in Jun. 2023 was $211.51 Mil.
BioPlus Acquisition's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.16 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioPlus Acquisition EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of BioPlus Acquisition's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

BioPlus Acquisition (BioPlus Acquisition) Business Description